IBD is characterized for driving Th1 and Th17 lymphocyte responses, such as production of IFN-γ, TNF-α, IL-1, IL-6, IL-8, and MIP-1α which trigger and maintain inflammation in the intestine, partly through neutrophil chemotaxis [115,123]. Here, IL6 is linked to irritable bowel syndrome.